459 related articles for article (PubMed ID: 36036505)
1. Systematic Analysis of Mobile Genetic Elements Mediating β-Lactamase Gene Amplification in Noncarbapenemase-Producing Carbapenem-Resistant
Shropshire WC; Konovalova A; McDaneld P; Gohel M; Strope B; Sahasrabhojane P; Tran CN; Greenberg D; Kim J; Zhan X; Aitken S; Bhatti M; Savidge TC; Treangen TJ; Hanson BM; Arias CA; Shelburne SA
mSystems; 2022 Oct; 7(5):e0047622. PubMed ID: 36036505
[TBL] [Abstract][Full Text] [Related]
2. IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort.
Shropshire WC; Aitken SL; Pifer R; Kim J; Bhatti MM; Li X; Kalia A; Galloway-Peña J; Sahasrabhojane P; Arias CA; Greenberg DE; Hanson BM; Shelburne SA
J Antimicrob Chemother; 2021 Jan; 76(2):385-395. PubMed ID: 33164081
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.
Wu AY; Chang H; Wang NY; Sun FJ; Liu CP
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1229-1238. PubMed ID: 34824020
[TBL] [Abstract][Full Text] [Related]
4. Role of association of OmpK35 and OmpK36 alteration and bla
Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
[TBL] [Abstract][Full Text] [Related]
5. Contribution of
Pal A; Dhara L; Tripathi A
Indian J Med Res; 2019 Apr; 149(4):528-538. PubMed ID: 31411177
[TBL] [Abstract][Full Text] [Related]
6.
Stewart AG; Cottrell K; Henderson A; Vemuri K; Bauer MJ; Paterson DL; Harris PNA
Microbiol Spectr; 2021 Sep; 9(1):e0022621. PubMed ID: 34232101
[TBL] [Abstract][Full Text] [Related]
7. Diverse Role of
Black CA; Benavides R; Bandy SM; Dallas SD; Gawrys G; So W; Moreira AG; Aguilar S; Quidilla K; Smelter DF; Reveles KR; Frei CR; Koeller JM; Lee GC
Antibiotics (Basel); 2024 Feb; 13(2):. PubMed ID: 38391571
[TBL] [Abstract][Full Text] [Related]
8. Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals.
Castanheira M; Doyle TB; Deshpande LM; Mendes RE; Sader HS
Int J Antimicrob Agents; 2021 Nov; 58(5):106439. PubMed ID: 34547421
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and characteristics of ertapenem-mono-resistant isolates among carbapenem-resistant Enterobacterales in China.
Wang Y; Hu H; Shi Q; Zhang P; Zhao D; Jiang Y; Yu Y
Emerg Microbes Infect; 2024 Dec; 13(1):2332658. PubMed ID: 38517707
[TBL] [Abstract][Full Text] [Related]
10. Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values.
Castanheira M; Doyle TB; Hubler C; Sader HS; Mendes RE
Int J Antimicrob Agents; 2020 Jul; 56(1):106011. PubMed ID: 32417206
[TBL] [Abstract][Full Text] [Related]
11. Carbapenem-Resistant and ESBL-Producing Enterobacterales Emerging in Central Texas.
Parker JK; Gu R; Estrera GA; Kirkpatrick B; Rose DT; Mavridou DAI; Mondy KE; Davies BW
Infect Drug Resist; 2023; 16():1249-1261. PubMed ID: 36891378
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
[TBL] [Abstract][Full Text] [Related]
13. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
14. High proportion of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae among extended-spectrum β-lactamase-producers in Nigerian hospitals.
Olalekan A; Onwugamba F; Iwalokun B; Mellmann A; Becker K; Schaumburg F
J Glob Antimicrob Resist; 2020 Jun; 21():8-12. PubMed ID: 31525542
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
Kim SY; Shin J; Shin SY; Ko KS
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of clinical isolation of carbapenem-resistant Enterobacterales and application of carbapenemase inhibitor enhancement test.
Li H; Zhong Y; Yan Q; Liu W; Liang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1210-1216. PubMed ID: 37875361
[TBL] [Abstract][Full Text] [Related]
17. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant
Shortridge D; Kantro V; Castanheira M
Microbiol Spectr; 2023 Feb; 11(1):e0450722. PubMed ID: 36622238
[TBL] [Abstract][Full Text] [Related]
18. β-lactam resistance associated with β-lactamase production and porin alteration in clinical isolates of E. coli and K. pneumoniae.
Khalifa SM; Abd El-Aziz AM; Hassan R; Abdelmegeed ES
PLoS One; 2021; 16(5):e0251594. PubMed ID: 34014957
[TBL] [Abstract][Full Text] [Related]
19. Carbapenemase-producing Enterobacterales strains causing infections in companion animals-Portugal.
Moreira da Silva J; Menezes J; Fernandes L; Santos Costa S; Amaral A; Pomba C
Microbiol Spectr; 2024 Apr; 12(4):e0341623. PubMed ID: 38446073
[TBL] [Abstract][Full Text] [Related]
20. High Prevalence of Carbapenem-Resistant Enterobacterales Producing OXA-48 among Carbapenem-Resistant Isolates in a Regional Hospital in Central Taiwan.
Wu LT; Nguyen HV; Ke SC; Lin YP; Pang YC; Guo MK; Chen CM
Jpn J Infect Dis; 2024 Mar; 77(2):83-90. PubMed ID: 38030272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
